User profiles for Nicholas Cho

Nicholas S Cho

- Verified email at g.ucla.edu - Cited by 114

Nicholas Cho

- Verified email at wustl.edu - Cited by 112

[HTML][HTML] Genomic insights into rapid speciation within the world's largest tree genus Syzygium

…, A Berhaman, RE Bone, M Cheek, NRW Cho… - Nature …, 2022 - nature.com
Species radiations, despite immense phenotypic variation, can be difficult to resolve
phylogenetically when genetic change poorly matches the rapidity of diversification. Genomic …

Preclinical development of CD38-targeted [89Zr] Zr-DFO-daratumumab for imaging multiple myeloma

A Ghai, D Maji, N Cho… - Journal of Nuclear …, 2018 - Soc Nuclear Med
Multiple myeloma (MM) is a plasma B-cell hematologic cancer that causes significant skeletal
morbidity. Despite improvements in survival, heterogeneity in response remains a major …

[HTML][HTML] Simultaneous quantification of perfusion, permeability, and leakage effects in brain gliomas using dynamic spin-and-gradient-echo echoplanar imaging MRI

F Sanvito, C Raymond, NS Cho, J Yao, A Hagiwara… - European …, 2023 - Springer
Objective To determine the feasibility and biologic correlations of dynamic susceptibility
contrast (DSC), dynamic contrast enhanced (DCE), and quantitative maps derived from contrast …

Diffusion MRI is an early biomarker of overall survival benefit in IDH wild-type recurrent glioblastoma treated with immune checkpoint inhibitors

A Hagiwara, TC Oughourlian, NS Cho… - Neuro …, 2022 - academic.oup.com
Background Diffusion MRI estimates of the apparent diffusion coefficient (ADC) have been
shown to be useful in predicting treatment response in patients with glioblastoma (GBM), with …

[HTML][HTML] Ablation of VLA4 in multiple myeloma cells redirects tumor spread and prolongs survival

D Hathi, C Chanswangphuwana, N Cho, F Fontana… - Scientific reports, 2022 - nature.com
Multiple myeloma (MM) is a cancer of bone marrow (BM) plasma cells, which is increasingly
treatable but still incurable. In 90% of MM patients, severe osteolysis results from …

Amine‐weighted chemical exchange saturation transfer magnetic resonance imaging in brain tumors

NS Cho, A Hagiwara, J Yao, DA Nathanson… - NMR in …, 2023 - Wiley Online Library
Amine‐weighted chemical exchange saturation transfer (CEST) magnetic resonance imaging
(MRI) is particularly valuable as an amine‐ and pH‐sensitive imaging technique in brain …

The feasibility of implementing targeted sedation in mechanically ventilated emergency department patients: the ED-SED pilot trial

…, RJ Stephens, T Sewatsky, NS Cho… - Critical care …, 2022 - journals.lww.com
OBJECTIVES: Deep sedation in the emergency department (ED) is common, increases deep
sedation in the ICU, and is negatively associated with outcome. Limiting ED deep sedation …

[HTML][HTML] Multi-nuclear sodium, diffusion, and perfusion MRI in human gliomas

NS Cho, F Sanvito, S Thakuria, C Wang… - Journal of neuro …, 2023 - Springer
Purpose There is limited knowledge about the associations between sodium and proton
MRI measurements in brain tumors. The purpose of this study was to quantify intra- and …

[HTML][HTML] A multi-reader comparison of normal-appearing white matter normalization techniques for perfusion and diffusion MRI in brain tumors

NS Cho, A Hagiwara, F Sanvito, BM Ellingson - Neuroradiology, 2023 - Springer
Purpose There remains no consensus normal-appearing white matter (NAWM) normalization
method to compute normalized relative cerebral blood volume (nrCBV) and apparent …

[HTML][HTML] The Future Glioblastoma Clinical Trials Landscape: Early Phase 0, Window of Opportunity, and Adaptive Phase I–III Studies

NS Cho, WK Wong, PL Nghiemphu… - Current Oncology …, 2023 - Springer
Purpose of Review Innovative clinical trial designs for glioblastoma (GBM) are needed to
expedite drug discovery. Phase 0, window of opportunity, and adaptive designs have been …